[{"Assets_0_Q1_USD":480108000.0,"CommonStockSharesOutstanding_0_Q1_shares":54798000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":49825000.0,"NetIncomeLoss_1_Q1_USD":-65087000.0,"StockholdersEquity_0_Q1_USD":63407000.0,"Ticker":"TBPH","CIK":"1583107","name":"THERAVANCE BIOPHARMA, INC.","OfficialName":"Theravance Biopharma Inc. Ordinary Shares","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"688048421.0","Country":"Cayman Islands","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180509"}]